{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:23Z","timestamp":1791994583044,"version":"4.4.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02687","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:45:22Z","timestamp":1542707122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Roxana M.","family":"Chiorean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayson B.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Lischka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel-Corneliu","family":"Leucuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasile","family":"Feldrihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassian","family":"Sitaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ni.1900","article-title":"Control systems and decision making for antibody production","volume":"11","author":"Goodnow","year":"2010","journal-title":"Nat Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"45","author":"Davidson","year":"2001","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/15665240113136660079","article-title":"Molecular diagnosis in autoimmune skin blistering conditions","volume":"14","author":"Otten","year":"2014","journal-title":"Curr Mol Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 Is Critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-070912-133235","article-title":"Anti-B cell antibody therapies for inflammatory rheumatic diseases","volume":"65","author":"Faurschou","year":"2014","journal-title":"Ann Rev Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1600-0625.2005.00367.x","article-title":"Mechanisms of blister induction by autoantibodies","volume":"14","author":"Sitaru","year":"2005","journal-title":"Exp Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nrrheum.2012.75","article-title":"Complement in the immunopathogenesis of rheumatic disease","volume":"8","author":"Sturfelt","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fmed.2015.00003","article-title":"Complement system in dermatological diseases - fire under the skin","volume":"2","author":"Panelius","year":"2015","journal-title":"Front Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"Lennon","year":"1978","journal-title":"J Exp Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1749-6632.2012.06783.x","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1172\/JCI118942","article-title":"Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice","volume":"98","author":"Lazarova","year":"1996","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.0022-202x.2001.01683.x","article-title":"Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid","volume":"118","author":"Yamamoto","year":"2002","journal-title":"J Invest Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.137.9.2835","article-title":"Defining the role of complement in experimental pemphigus vulgaris in mice","volume":"137","author":"Anhalt","year":"1986","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2016.07.021","article-title":"Autoimmunity against laminins","volume":"170","author":"Florea","year":"2016","journal-title":"Clin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5aR2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/jid.2009.12","article-title":"Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease","volume":"129","author":"Sitaru","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1172\/JCI107288","article-title":"The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids","volume":"52","author":"Jordon","year":"1973","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1172\/JCI108412","article-title":"The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of \u201cHG factor.\u201d","volume":"57","author":"Jordon","year":"1976","journal-title":"J Clin Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7746","DOI":"10.4049\/jimmunol.1000667","article-title":"Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (Type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/1523-1747.ep12507222","article-title":"An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement","volume":"78","author":"Gammon","year":"1982","journal-title":"J Invest Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin","volume":"118","author":"Sitaru","year":"2002","journal-title":"J Invest Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1684\/ejd.2007.0090","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze","year":"2007","journal-title":"Eur J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci."},{"key":"B40","unstructured":"ViennaR Foundation for Statistical ComputingR: A Language And Environment for Statistical Computing.2010"},{"key":"B41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/1523-1747.ep12598113","article-title":"Complement activation in bullous skin diseases","volume":"65","author":"Jordon","year":"1975","journal-title":"J Invest Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"72s","DOI":"10.1111\/1523-1747.ep12275497","article-title":"Immunopathologic mechanisms in pemphigus and bullous pemphigoid","volume":"85","author":"Jordon","year":"1985","journal-title":"J Invest Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/1523-1747.ep12261694","article-title":"Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods","volume":"83","author":"Gammon","year":"1984","journal-title":"J Invest Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e31066","DOI":"10.1371\/journal.pone.0031066","article-title":"The flavonoid luteolin inhibits Fc\u03b3-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice","volume":"7","author":"Oswald","year":"2012","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1172-8-17","article-title":"Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice","volume":"8","author":"Chiriac","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00109-008-0366-7","article-title":"Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita","volume":"86","author":"Sesarman","year":"2008","journal-title":"J Mol Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/jid.2014.443","article-title":"Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice","volume":"135","author":"Hurskainen","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/jid.2014.537","article-title":"Itch, eosinophils, and autoimmunity: a novel murine model of bullous pemphigoid","volume":"135","author":"Yancey","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-biophys-051013-022826","article-title":"Itch mechanisms and circuits","volume":"43","author":"Han","year":"2014","journal-title":"Annu Rev Biophys."},{"key":"B55","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jaci.2010.11.002","article-title":"Eosinophil extracellular DNA traps in skin diseases","volume":"127","author":"Simon","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/jdv.12136","article-title":"Immunopathological characteristics of patients with bullous pemphigoid and neurological disease","volume":"28","author":"Taghipour","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jdv.12995","article-title":"Neurological disorders in patients with bullous pemphigoid: clinical and experimental investigations","volume":"29","author":"Gambichler","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.hoc.2015.01.009","article-title":"Current and future pharmacologic complement inhibitors","volume":"29","author":"Risitano","year":"2015","journal-title":"Hematol Oncol Clin North Am."},{"key":"B63","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5414\/CN107220","article-title":"Therapeutic regulation of complement in patients with renal disease - where is the promise?","volume":"77","author":"Thurman","year":"2012","journal-title":"Clin Nephrol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1172\/JCI108413","article-title":"Herpes gestationis. Immunopathology and characterization of the HG factor","volume":"57","author":"Katz","year":"1976","journal-title":"J Clin Invest."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"De Graauw","year":"2017","journal-title":"Allergy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02687\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T05:43:04Z","timestamp":1694065384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02687\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2018.02687"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02687","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734636657.793576370","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"article-number":"2687"}}